Metrikler
Yayın
181
Açık Erişim
19
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2003 - 2007
2003 - 2007Doktora
Hacettepe Üniversitesi, Sağlık Bilimleri Enstitüsü, Kanser Enstitüsü Temel Onkoloji Anabilim Dalı, Türkiye
2001 - 2003
2001 - 2003Yüksek Lisans
Hacettepe Üniversitesi, Sağlık Bilimleri Enstitüsü, Kanser Enstitüsü Temel Onkoloji Anabilim Dalı, Türkiye
1997 - 2001
1997 - 2001Lisans
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Tıbbi Biyolojik Bilimler Bölümü, Türkiye
Yaptığı Tezler
2007
2007Doktora
Kimyasal karsinojenezle oluşturulmuş meme tümör hücrelerinin CD40 ligand ile genetik modifikasyonu ve allojenik aşı preparatı olarak kullanılabilirliğinin değerlendirilmesi
Hacettepe Üniversitesi, Kanser Enstitüsü, Tümör Biyolojisi Ve İmmünolojisi (Yl) (Tezli)
2003
2003Yüksek Lisans
CD40 ligand (CD154) genin ökaryotik ekspresyon vektörüne klonlanması
Hacettepe Üniversitesi, Kanser Enstitüsü, Temel İmmünoloji (Yl) (Tezli)
Yabancı Diller
B2 Orta Üstü
B2 Orta Üstüİngilizce
B1 Orta
B1 OrtaFransızca
Araştırma Alanları
Tıp
Sağlık Bilimleri
Temel Tıp Bilimleri
Mikrobiyoloji ve Klinik Mikrobiyoloji
İmmünoloji
Tıbbi Biyoloji
Yaşam Bilimleri
Moleküler Biyoloji ve Genetik
Kanser Moleküler Biyolojisi
Temel Bilimler
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2018 - Devam Ediyor
2018 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Kanser Enstitüsü, Temel Onkoloji A.B.D.
Yönetimsel Görevler
2012 - Devam Ediyor
2012 - Devam EdiyorErasmus Programı Kurum Koordinatörü
Hacettepe Üniversitesi, Kanser Enstitüsü
2017 - 2019
2017 - 2019Üniversite Yönetim Kurulu Üyesi
Hacettepe Üniversitesi
Yönetilen Tezler
2015
2015Yüksek Lisans
The effect of inducible costimulatory ligand (İCOS-LG) expressing myeloid leukemia cells on helper t lymphocyte activation and exhaustion
ESENDAĞLI G.
D.ÖZKAZANÇ(Öğrenci)
2014
2014Yüksek Lisans
All-trans retinoik asit (ATRA) ve 1α,25-dihidroksivitamin D3 (vitamin D3) ile uyarılan akut miyeloid lösemi hücrelerinin T hücre yanıtları üzerine etkisi
ESENDAĞLI G.
D.YÖYEN(Öğrenci)
2011
2011Doktora
Fibroblast-breast cancer cells' interaction and Chemerin expression
GÜÇ D., ESENDAĞLI G.
D.RAMA(Öğrenci)
Makaleler
Tümü (104)
SCI-E, SSCI, AHCI (100)
SCI-E, SSCI, AHCI, ESCI (101)
ESCI (1)
Scopus (101)
TRDizin (7)
Diğer Yayınlar (1)
2025
20251. Design, characterization, and in vitro/in vivo evaluation of HER2-targeted immunoliposomes co-functionalized with trastuzumab and iRGD for enhanced delivery of oxaliplatin in gastric cancer therapy
Fidan Y., Aras I. A., SİLİNDİR GÜNAY M., TİMUR S. S., ÖZTÜRK S., ESENDAĞLI G., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, cilt.113, 2025 (SCI-Expanded, Scopus)
2025
20252. IL-8 contributes to functional diversity of tumor-infiltrating neutrophils: A new target for cancer immunotherapy
Tavukcuoglu E., ESENDAĞLI G.
DEVELOPMENTAL CELL
, sa.3, ss.339-341, 2025 (SCI-Expanded, Scopus)
2024
20243. Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis
ARSLAN D., ERGÜL ÜLGER Z., Goksen S., ESENDAĞLI G., ERDEM ÖZDAMAR S., Tan E., et al.
EUROPEAN NEUROLOGY
, cilt.87, sa.5-6, ss.223-229, 2024 (SCI-Expanded, Scopus)
2024
20244. A Phosphatidyl Conjugated Telomerase-Dependent Telomere-Targeting Nucleoside Demonstrates Colorectal Cancer Direct Killing and Immune Signaling
YILMAZ M., Goksen S., Mender I., ESENDAĞLI G., ERDENER Ş. E., Ahmed A., et al.
BIOMOLECULES
, cilt.14, sa.12, 2024 (SCI-Expanded, Scopus)
2024
20245. Preparation and in vitro characterization of memantine HCl loaded PLGA nanoparticles for Alzheimer's disease
Tezel G., Uluturk S., REÇBER T., TİMUR S. S., NEMUTLU E., ESENDAĞLI G., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, cilt.100, 2024 (SCI-Expanded, Scopus)
2024
20246. Evaluation of Myeloid-Derived Suppressor Cells in Newly Diagnosed MS Patients
Acar N. P., Yanik H., ESENDAĞLI G., KARABUDAK R., TUNCER M. A.
MULTIPLE SCLEROSIS JOURNAL
, sa.3, ss.887-888, 2024 (SCI-Expanded, Scopus)
2024
20247. Folate Receptor β (FRβ) Expression on Myeloid Cells and the Impact of Reticuloendothelial System on Folate-Functionalized Nanoparticles' Biodistribution in Cancer
Goksen S., Varan G., Bilensoy E., Esendagli G.
MOLECULAR PHARMACEUTICS
, sa.9, ss.4688-4699, 2024 (SCI-Expanded, Scopus)
2024
20248. Acquired immune resistance is associated with interferon signature and modulation of KLF6/c-MYB transcription factors in myeloid leukemia
Parveen M., KARAOSMANOĞLU B., SUCULARLI C., ÜNER A., TAŞKIRAN Z. E., ESENDAĞLI G.
European Journal of Immunology
, 2024 (SCI-Expanded, Scopus)
2024
20249. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.
Tonbul H., Şahin A., Öztürk S. C., Ultav G., Tavukçuoğlu E., Akbaş S., et al.
Journal of drug targeting
, cilt.32, ss.1101-1110, 2024 (SCI-Expanded, Scopus)
2023
202310. The Effect of Paclitaxel with a STAT3 Pathway Inhibitor on Metastasis in the Treatment of Triple Negative Breast Cancer
DİNÇSOY A. B., GEDİKLİ E., ÖZTÜRK S. C., Nikshiqi E., Baris V. O., KARAKOÇ E., et al.
ACTA PHYSIOLOGICA
, ss.45, 2023 (SCI-Expanded, Scopus)
2023
202311. Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
Tavukcuoglu E., Yanik H., Parveen M., Uluturk S., DURUSU TANRIÖVER M., İNKAYA A. Ç., et al.
Scientific Reports
, cilt.13, sa.1, 2023 (SCI-Expanded, Scopus)
2023
202312. Immune checkpoint status and exhaustion-related phenotypes of CD8+ T cells from the tumor-draining regional lymph nodes in breast cancer
Yilmaz I., Tavukcuoglu E., Horzum U., Yilmaz K. B., Akinci M., Gulcelik M. A., et al.
Cancer Medicine
, cilt.12, sa.24, ss.22196-22205, 2023 (SCI-Expanded, Scopus)
2023
202313. Liver resection modulates hepatic chemokine levels in breast cancer
DİNÇER H. A., Horzum U., Kursunel M. A., Yoyen-Ermis D., Ermis E., ÖZOĞUL E., et al.
Surgery (United States)
, cilt.174, sa.2, ss.277-282, 2023 (SCI-Expanded, Scopus)
2023
202314. Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors
Anthiya S., ÖZTÜRK S. C., Yanik H., Tavukcuoglu E., ŞAHİN A., Datta D., et al.
Journal of Controlled Release
, cilt.357, ss.67-83, 2023 (SCI-Expanded, Scopus)
2023
202315. The synthesis and anti-cancer efficacy of endoperoxide modified copper sulfide-ferritin nanocages as PDT and PTT agents
Kucukoflaz M., Ulusoy S., Korkmaz B., ÖZTÜRK S. C., AKYOL M., Hayta S. B., et al.
Journal of Nanoparticle Research
, cilt.25, sa.4, 2023 (SCI-Expanded, Scopus)
2023
202316. A positive feedback loop driven by fibronectin and IL-1β sustains the inflammatory microenvironment in breast cancer
TUNALI G., Yanik H., ÖZTÜRK S. C., DEMİRKOL CANLI S., Efthymiou G., Yilmaz K. B., et al.
Breast cancer research : BCR
, cilt.25, sa.1, ss.27, 2023 (SCI-Expanded, Scopus)
2023
202317. A novel combination for the treatment of small cell lung cancer: Active targeted irinotecan and stattic co-loaded PLGA nanoparticles
Arslan F. B., ÖZTÜRK K., Tavukçuoğlu E., ÖZTÜRK S. C., ESENDAĞLI G., ÇALIŞ S.
International Journal of Pharmaceutics
, cilt.632, 2023 (SCI-Expanded, Scopus)
2023
202318. Effects of Particle Geometry for PLGA-Based Nanoparticles: Preparation and In Vitro/In Vivo Evaluation
Kaplan M., ÖZTÜRK K., ÖZTÜRK S. C., Tavukçuoğlu E., ESENDAĞLI G., ÇALIŞ S.
Pharmaceutics
, cilt.15, sa.1, 2023 (SCI-Expanded, Scopus)
2023
202319. Characterization of serum extracellular vesicles and their differential level of miR-197-3p in familial Mediterranean fever patients
Tavukcuoglu Z., AKKAYA ULUM Z. Y., YERSAL N., Horzum U., AKBABA T. H., KARADAĞ Ö., et al.
Nucleosides, Nucleotides and Nucleic Acids
, 2023 (SCI-Expanded, Scopus)
2023
202320. Pro-fibrogenic and adipogenic aspects of chronic muscle degeneration are contributed by distinct stromal cell subpopulations
ÖZDEMİR SAKA C., Akçay D., Yöyen-Ermiş D., Taşkıran E. Z., Soylu-Kucharz R., ESENDAĞLI G., et al.
PloS one
, cilt.18, sa.7, 2023 (SCI-Expanded, Scopus)
2022
202221. Tailored modulation of stemness and drug resistance marker characteristics in K-Ras mutant lung cancer cells via PD-L1 gene suppression.
Unver N., Tavukcuoglu E., Esendagli G.
Life sciences
, cilt.311, ss.121171, 2022 (SCI-Expanded, Scopus)
2022
202222. Effector Th1 cells under PD-1 and CTLA-4 checkpoint blockade abrogate the upregulation of multiple inhibitory receptors and by-pass exhaustion
Horzum U., Yanik H., Taskiran E. Z., Esendagli G.
IMMUNOLOGY
, cilt.167, sa.4, ss.640-650, 2022 (SCI-Expanded, Scopus)
2022
202223. Memory T cell responses in seronegative older adults following SARS-CoV-2 vaccination.
Hafızoğlu M., Bas A. O., Tavukçuoğlu E., Sahiner Z., Oytun M. G., Ulutürk S., et al.
Clinical immunology communications
, cilt.2, ss.154-158, 2022 (TRDizin)
2022
202224. Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes
KURŞUNEL M. A., Taskiran E. Z., Tavukcuoglu E., Yanik H., Demirag F., KARAOSMANOĞLU B., et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY
, cilt.71, sa.2, ss.445-459, 2022 (SCI-Expanded, Scopus)
2021
202125. Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier
Seko I., TONBUL H., Tavukcuoglu E., Sahin A., AKBAŞ S., Yanik H., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, cilt.66, 2021 (SCI-Expanded, Scopus)
2021
202126. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model
Unal S., ÖZTÜRK S. C., BİLGİÇ E., Yanik H., KORKUSUZ P., AKTAŞ Y., et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
, cilt.169, ss.168-177, 2021 (SCI-Expanded, Scopus)
2021
202127. Functional responsiveness of memory T cells from COVID-19 patients
Tavukcuoglu E., Horzum U., İNKAYA A. Ç., ÜNAL S., ESENDAĞLI G.
CELLULAR IMMUNOLOGY
, cilt.365, 2021 (SCI-Expanded, Scopus)
2021
202128. Proerythroblast Cells of Diamond-Blackfan Anemia Patients With RPS19 and CECR1 Mutations Have Similar Transcriptomic Signature
KARAOSMANOĞLU B., KURŞUNEL M. A., ÇETİNKAYA F. D., GÜMRÜK F., ESENDAĞLI G., ÜNAL Ş., et al.
FRONTIERS IN PHYSIOLOGY
, cilt.12, 2021 (SCI-Expanded, Scopus)
2021
202129. Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells
TONBUL H., Sahin A., Tavukcuoglu E., Ultav G., AKBAŞ S., AKTAŞ Y., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, cilt.63, 2021 (SCI-Expanded, Scopus)
2021
202130. A robust optimization approach for the breast cancer targeted design of PEtOx-b-PLA polymersomes
ÖZ U. C., Bolat Z. B., Ozkose U. U., Gulyuz S., KÜÇÜKTÜRKMEN B., PARLAK KHALİLY M., et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
, cilt.123, 2021 (SCI-Expanded, Scopus)
2021
202131. Clinical Relevance of Polymorphonuclear Myeloid-Derived Suppressor Cells in Autoimmune-Blistering Disorders Pemphigus Vulgaris and Bullous Pemphigoid
Oktem A., Horzum U., Ertop P., KUNDAKCI N., Akay B. N., Yalcin B., et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY
, cilt.141, sa.3, ss.672-676, 2021 (SCI-Expanded, Scopus)
2021
202132. Therapeutic efficacy and biodistribution of paclitaxel-bound amphiphilic cyclodextrin nanoparticles: Analyses in 3D tumor culture and tumor-bearing animals in vivo
Varan G., Varan C., Öztürk S. C., Benito J. M., Esendağlı G., Bilensoy E.
Nanomaterials
, cilt.11, sa.2, ss.1-18, 2021 (SCI-Expanded, Scopus)
2021
202133. CD66b(+)monocytes represent a proinflammatory myeloid subpopulation in cancer
Horzum U., Yoyen-Ermis D., Taskiran E. Z., Yilmaz K. B., HAMALOĞLU E., KARAKOÇ D., et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY
, cilt.70, sa.1, ss.75-87, 2021 (SCI-Expanded, Scopus)
2021
202134. Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer
Karpuz M., Silindir-Gunay M., Ozer A. Y., Ozturk S. C., Yanik H., Tuncel M., et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
, cilt.156, 2021 (SCI-Expanded, Scopus)
2020
202035. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer
Tavukcuoglu E., Horzum U., Yanik H., ÜNER A., Yoyen-Ermis D., NURAL S. K., et al.
EUROPEAN JOURNAL OF IMMUNOLOGY
, cilt.50, sa.12, ss.2067-2074, 2020 (SCI-Expanded, Scopus)
2020
202036. An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta 1 and fingolimod therapy
Acar N. P., Tuncer A., Ozkazanc D., Ozbay F. G., KARAOSMANOĞLU B., Goksen S., et al.
JOURNAL OF NEUROIMMUNOLOGY
, cilt.347, 2020 (SCI-Expanded, Scopus)
2020
202037. Design and synthesis of novel peptidomimetics for cancer immunotherapy
Kose C., Uysal E., Yazici B., Tugay Z., Dingis-Birgul S. I., Yanik H., et al.
ORGANIC COMMUNICATIONS
, cilt.13, sa.3, ss.89-102, 2020 (ESCI, Scopus, TRDizin)
2020
202038. Development and in vitro evaluation of temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme
Sayiner O., Arisoy S., ÇOMOĞLU T., Ozbay F. G., ESENDAĞLI G.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, cilt.57, 2020 (SCI-Expanded, Scopus)
2020
202039. Design and in vitro evaluation of folate-targeted, co-drug encapsulated theranostic liposomes for non-small cell lung cancer
KARPUZ M., Silindir-Gunay M., Kursunel M. A., ESENDAĞLI G., DOĞAN A., ÖZER A. Y.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, cilt.57, 2020 (SCI-Expanded, Scopus)
2020
202040. Transcriptional splice variants of CD40 and its prognostic value in breast cancer.
Ünver N., Yöyen E., Weber B., Esendağli G.
Turkish journal of biology = Turk biyoloji dergisi
, cilt.44, ss.73-81, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202041. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration
Caban-Toktas S., Sahin A., Lule S., Esendagli G., Vural İ., Karlı Oguz K., et al.
International Journal of Pharmaceutics
, cilt.578, 2020 (SCI-Expanded, Scopus)
2020
202042. Development and in vitro evaluation of a new adjuvant system containing Salmonella Typhi porins and chitosan
YÜKSEL S., PEKCAN M., PURALI N., ESENDAĞLI G., Tavukcuoglu E., Rivero-Arredondo V., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.578, 2020 (SCI-Expanded, Scopus)
2020
202043. Aggregation of chitosan nanoparticles in cell culture: Reasons and resolutions
Ozturk K., Arslan F. B., Tavukcuoglu E., ESENDAĞLI G., ÇALIŞ S.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.578, 2020 (SCI-Expanded, Scopus)
2020
202044. PD-L2(+) wound zone macrophage-like cells display M1/M2-mixed activation and restrain the effector Th1 responses
Tavukcuoglu E., Horzum U., Yilmaz K. B., ESENDAĞLI G.
IMMUNOLOGY AND CELL BIOLOGY
, cilt.98, sa.2, ss.152-164, 2020 (SCI-Expanded, Scopus)
2020
202045. Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation
Cassetta L., Bruderek K., Skrzeczynska-Moncznik J., Osiecka O., Hu X., Rundgren I. M., et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
, cilt.8, sa.2, 2020 (SCI-Expanded, Scopus)
2020
202046. Protocol to assess the suppression of T-cell proliferation by human MDSC
Bruger A. M., Vanhaver C., Bruderek K., Amodio G., Tavukcuoglu E., ESENDAĞLI G., et al.
TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - CELLULAR METHODS, PT B
, cilt.632, ss.155-192, 2020 (SCI-Expanded, Scopus)
2019
201947. A method for high-purity isolation of neutrophil granulocytes for functional cell migration assays
Avci E., Akkaya-Ulum Y. Z., Yoyen-Ermis D., ESENDAĞLI G., Balci-Peynircioglu B.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
, cilt.44, sa.6, ss.810-821, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201948. Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer
Tonbul H., Sahin A., Tavukcuoglu E., ESENDAĞLI G., ÇAPAN Y.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, cilt.54, 2019 (SCI-Expanded, Scopus)
2019
201949. Identification of circulating MOG-specific B cells in patients with MOG antibodies
Winklmeier S., Schlueter M., Spadaro M., Thaler F. S., Vural A., Gerhards R., et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
, cilt.6, sa.6, 2019 (SCI-Expanded, Scopus)
2019
201950. Myeloid maturation potentiates STAT3-mediated atypical IFN-gamma signaling and upregulation of PD-1 ligands in AML and MDS
Yoyen-Ermis D., Tunali G., Tavukcuoglu E., Horzum U., Ozkazanc D., Sutlu T., et al.
SCIENTIFIC REPORTS
, cilt.9, 2019 (SCI-Expanded, Scopus)
2019
201951. Primary tumor resection for initially staged IV breast cancer An emphasis on programmed death-ligand 1 expression, promoter methylation status, and survival
Erol T., İmamoğlu N., Aydin B., Taşkiran Z. E., Esendağli G., Kösemehmetoğlu K., et al.
MEDICINE
, cilt.98, sa.33, 2019 (SCI-Expanded, Scopus)
2019
201952. Dual actions of the antioxidant chlorophyllin, a glutathione transferase P1-1 inhibitor, in tumorigenesis and tumor progression
ÖZCAN M., ESENDAĞLI G., Musdal Y., CANPINAR H., BACANLI M., Anlar H. G., et al.
JOURNAL OF CELLULAR BIOCHEMISTRY
, cilt.120, sa.5, ss.7045-7055, 2019 (SCI-Expanded, Scopus)
2019
201953. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions
Bruger A. M., Dorhoi A., ESENDAĞLI G., Barczyk-Kahlert K., van der Bruggen P., Lipoldova M., et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY
, cilt.68, sa.4, ss.631-644, 2019 (SCI-Expanded, Scopus)
2019
201954. Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer
TİMUR S. S., Yoyen-Ermis D., Esendagli G., Yonat S., Horzum U., ESENDAĞLI G., et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
, cilt.136, ss.138-146, 2019 (SCI-Expanded, Scopus)
2019
201955. A Novel Missense LIG4 Mutation in a Patient With a Phenotype Mimicking Behcet's Disease
Taskiran E., Sonmez H., Kosukcu C., Tavukcuoglu E., Yazici G., Esendagli G., et al.
JOURNAL OF CLINICAL IMMUNOLOGY
, cilt.39, sa.1, ss.99-105, 2019 (SCI-Expanded, Scopus)
2018
201856. The fibrogenic activation kinetics of stromal stem cells in three different skeletal muscle degeneration models
Ozdemir C., Akcay D., Ermis D. Y., ESENDAĞLI G., Kocaefe C.
FEBS OPEN BIO
, cilt.8, ss.93, 2018 (SCI-Expanded, Scopus)
2018
201857. Dual Effect of Glucocorticoid-Induced Tumor Necrosis Factor-Related Receptor Ligand Carrying Mesenchymal Stromal Cells on Small Cell Lung Cancer: A Preliminary in vitro Study
KÖPRÜ C. Z., Cagnan I., AKAR İ., ESENDAĞLI G., KORKUSUZ P., Gunel-Ozcan A.
CYTOTHERAPY
, cilt.20, sa.7, ss.930-940, 2018 (SCI-Expanded, Scopus)
2018
201858. Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody
Yoyen-Ermis D., Ozturk-Atar K., KURŞUNEL M. A., Aydin C., Ozkazanc D., Gurbuz M. U., et al.
MOLECULAR PHARMACEUTICS
, cilt.15, sa.4, ss.1526-1533, 2018 (SCI-Expanded, Scopus)
2018
201859. Impact of repeated abdominal surgery on wound healing and myeloid cell dynamics
ESENDAĞLI G., Yoyen-Ermis D., Guseinov E., Aras C., Aydin C., ÜNER A., et al.
JOURNAL OF SURGICAL RESEARCH
, cilt.223, ss.188-197, 2018 (SCI-Expanded, Scopus)
2018
201860. Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer
ERDOĞAR N., ESENDAĞLI G., Nielsen T. T., Esendagli-Yilmaz G., Yoyen-Ermis D., Erdogdu B., et al.
JOURNAL OF DRUG TARGETING
, cilt.26, sa.1, ss.66-74, 2018 (SCI-Expanded, Scopus)
2018
201861. Development of novel self-assembled polymeric micelles from partially hydrolysed poly(2-ethyl-2-oxazoline)-co-PEI-b-PCL block copolymer as non-viral vectors for plasmid DNA in vitro transfection
Kara A., Ozturk N., ESENDAĞLI G., Ozkose U. U., Gulyuz S., Yilmaz O., et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
, cilt.46, 2018 (SCI-Expanded, Scopus)
2017
201762. Effect of Usnic Acid/Paclitaxel Co-Administration on Mouse (4T1) Breast Cancer Cell Lines
DİNÇSOY A. B., Ermis D. Y., CANSARAN DUMAN D., TUNCER M., KARABULUT İ., ESENDAĞLI G.
ACTA PHYSIOLOGICA
, cilt.221, ss.40-41, 2017 (SCI-Expanded, Scopus)
2017
201763. A Co-Inhibitory Alliance in Myeloid Leukemia: TIM-3/Galectin-9 Complex as a New Target for Checkpoint Blockade Therapy
KURŞUNEL M. A., ESENDAĞLI G.
EBIOMEDICINE
, cilt.23, ss.6-7, 2017 (SCI-Expanded, Scopus)
2017
201764. Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers
Ozturk K., ESENDAĞLI G., Gurbuz M. U., TÜLÜ M., ÇALIŞ S.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.517, ss.157-167, 2017 (SCI-Expanded, Scopus)
2017
201765. Splenectomy-Induced Leukocytosis Promotes Intratumoral Accumulation of Myeloid-Derived Suppressor Cells, Angiogenesis and Metastasis
Sevmis M., Yoyen-Ermis D., Aydin C., BİLGİÇ E., KORKUSUZ P., ÜNER A., et al.
IMMUNOLOGICAL INVESTIGATIONS
, cilt.46, sa.7, ss.663-676, 2017 (SCI-Expanded, Scopus)
2017
201766. Evaluation of brain-targeted chitosan nanoparticles through blood-brain barrier cerebral microvessel endothelial cells
Sahin A., Yoyen-Ermis D., Caban-Toktas S., Horzum U., AKTAŞ Y., Couvreur P., et al.
JOURNAL OF MICROENCAPSULATION
, cilt.34, sa.7, ss.659-666, 2017 (SCI-Expanded, Scopus)
2017
201767. Tümörlerde Doğal İmmün Yanıt
ÖZMEN F., ESENDAĞLI G.
Turkiye Klinikleri J Med Oncol-Special Topics , cilt.10, ss.104-111, 2017 (Hakemli Dergi)
2017
201768. Th1 cells in cancer-associated inflammation
Dinc Akbulut G., Ozkazanc D., ESENDAĞLI G.
TURKISH JOURNAL OF BIOLOGY
, cilt.41, sa.1, ss.20-30, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
201769. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery
ŞAHİN A., ESENDAĞLI G., YERLİKAYA F., Caban-Toktas S., Yoyen-Ermis D., HORZUM U., et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
, cilt.45, sa.8, ss.1657-1664, 2017 (SCI-Expanded, Scopus)
2016
201670. Functional exhaustion of CD4(+) T cells induced by co-stimulatory signals from myeloid leukaemia cells
Özkazanç D., Yöyen-Ermiş D., Tavukçuoğlu E., BÜYÜKAŞIK Y., ESENDAĞLI G.
IMMUNOLOGY
, cilt.149, sa.4, ss.460-471, 2016 (SCI-Expanded, Scopus)
2016
201671. The untold story of IFN-gamma in cancer biology
KURŞUNEL M. A., ESENDAĞLI G.
CYTOKINE & GROWTH FACTOR REVIEWS
, cilt.31, ss.73-81, 2016 (SCI-Expanded, Scopus)
2016
201672. Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles
ERDOĞAR N., ESENDAĞLI G., Nielsen T. T., ŞEN M., ÖNER L., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.509, ss.375-390, 2016 (SCI-Expanded, Scopus)
2016
201673. Atypical Chemokine Receptors in Cancer
sarmadi p., TUNALI G., ESENDAĞLI G.
Acta Medica
, 2016 (TRDizin)
2016
201674. Cytotoxicity and biodistribution studies on PEGylated EDA and PEG cored PAMAM dendrimers
Gurbuz M. U., Ozturk K., Erturk A. S., YOYEN-ERMIS D., ESENDAĞLI G., ÇALIŞ S., et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
, cilt.27, sa.16, ss.1645-1658, 2016 (SCI-Expanded, Scopus)
2015
201575. CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression: CXCL7-induced macrophage chemotaxis in LLC tumors.
Unver N., ESENDAGLI G., YILMAZ G., GUC D.
Cytokine
, cilt.75, ss.330-7, 2015 (SCI-Expanded, Scopus)
2015
201576. Immune system in cancer and hydatid disease: cross-reactivity vs. immune modulation
ESENDAĞLI G., ABBASOĞLU O.
PARASITE IMMUNOLOGY
, cilt.37, sa.8, ss.427-428, 2015 (SCI-Expanded, Scopus)
2015
201577. Granulocytic subset of myeloid derived suppressor cells in rats with mammary carcinoma
DOLEN Y., GÜNAYDIN G., ESENDAĞLI G., Guc D.
CELLULAR IMMUNOLOGY
, cilt.295, sa.1, ss.29-35, 2015 (SCI-Expanded, Scopus)
2015
201578. CRAM-A indicates IFN-gamma-associated inflammatory response in breast cancer
SARMADI P., Tunali G., Esendagli-Yilmaz G., YILMAZ K. B., ESENDAĞLI G.
MOLECULAR IMMUNOLOGY
, cilt.68, sa.2, ss.692-698, 2015 (SCI-Expanded, Scopus)
2015
201579. Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes' stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide
KILIÇ A., ESENDAĞLI G., SAYAT G., TALİM B., KARABUDAK R., KURNE A.
AUTOIMMUNITY
, cilt.48, sa.6, ss.423-428, 2015 (SCI-Expanded, Scopus)
2015
201580. Co-existence of Echinococcus granulosus infection and cancer metastasis in the liver correlates with reduced Th1 immune responses
Turhan N., ESENDAĞLI G., Ozkayar O., Tunali G., SÖKMENSÜER C., ABBASOĞLU O.
PARASITE IMMUNOLOGY
, cilt.37, sa.1, ss.16-22, 2015 (SCI-Expanded, Scopus)
2014
201481. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands
Karasar P., ESENDAĞLI G.
BREAST CANCER RESEARCH AND TREATMENT
, cilt.145, sa.3, ss.605-614, 2014 (SCI-Expanded, Scopus)
2014
201482. Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer
Rama-Esendagli D., ESENDAĞLI G., Yilmaz G., Guc D.
MOLECULAR BIOLOGY REPORTS
, cilt.41, sa.5, ss.2885-2892, 2014 (SCI-Expanded, Scopus)
2014
201483. Surface modification and evaluation of PLGA nanoparticles: the effects on cellular uptake and cell proliferation on the HT-29 cell line
Sengel-Turk C. T., Hascicek C., DOĞAN A., ESENDAĞLI G., Guc D., Gonul N.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, cilt.24, sa.2, ss.166-172, 2014 (SCI-Expanded, Scopus)
2013
201384. A co-stimulatory trap set by myeloid leukemia cells
Esendagli G.
ONCOIMMUNOLOGY
, cilt.2, sa.6, 2013 (SCI-Expanded, Scopus)
2013
201385. Myeloid leukemia cells with a B7-2(+) subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands
Dolen Y., ESENDAĞLI G.
EUROPEAN JOURNAL OF IMMUNOLOGY
, cilt.43, sa.3, ss.747-757, 2013 (SCI-Expanded, Scopus)
2013
201386. Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy
ESENDAĞLI G., Kurne A. T., Sayat G., Kilic A. K., Guc D., KARABUDAK R.
JOURNAL OF NEUROIMMUNOLOGY
, cilt.255, ss.81-84, 2013 (SCI-Expanded, Scopus)
2013
201387. The effect of granulocyte colony stimulating factor receptor gene missense single nucleotide polymorphisms on peripheral blood stem cell enrichment
CAMURDANOGLU B. Z., ESENDAĞLI G., Ozdemir E., CANPINAR H., Guc D., Kansu E.
CYTOKINE
, cilt.61, sa.2, ss.572-577, 2013 (SCI-Expanded, Scopus)
2012
201288. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells
Sengel-Turk C. T., Hascicek C., DOĞAN A., ESENDAĞLI G., Guc D., Gonul N.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
, cilt.38, sa.9, ss.1107-1116, 2012 (SCI-Expanded, Scopus)
2012
201289. Injectable biodegradable polymeric system for preserving the active form and delayed-release of camptothecin anticancer drugs
Mert O., ESENDAĞLI G., DOĞAN A., DEMİR A. G.
RSC ADVANCES
, cilt.2, sa.1, ss.176-185, 2012 (SCI-Expanded, Scopus)
2011
201190. Analysis of BAFF and TRAIL expression levels in multiple sclerosis patients: evaluation of expression under immunomodulatory therapy
Kurne A., Guc D., CANPINAR H., Aydin O. F., Sayat G., Yorubulut M., et al.
ACTA NEUROLOGICA SCANDINAVICA
, cilt.123, sa.1, ss.8-12, 2011 (SCI-Expanded, Scopus)
2011
201191. Expression of chemokine-like receptor 1 (CMKLR1) on J744A.1 macrophages co-cultured with fibroblast and/or tumor cells: Modeling the influence of microenvironment
Rama D., ESENDAĞLI G., Guc D.
CELLULAR IMMUNOLOGY
, cilt.271, sa.1, ss.134-140, 2011 (SCI-Expanded, Scopus)
2010
201092. Immune Compartmentalization of T cell Subsets in Chemically-induced Breast Cancer
Fahmi T., ESENDAĞLI G., Yilmaz G., Kansu E., Guc D.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY
, cilt.72, sa.4, ss.339-348, 2010 (SCI-Expanded, Scopus)
2010
201093. CD40-1C > T single nucleotide polymorphism and CD40 expression on breast tumors
Dolen Y., Yilmaz G., ESENDAĞLI G., Guler N. E., Guc D.
CYTOKINE
, cilt.50, sa.3, ss.243-244, 2010 (SCI-Expanded, Scopus)
2009
200994. Transfection of myeloid leukaemia cell lines is distinctively regulated by fibronectin substratum
ESENDAĞLI G., CANPINAR H., DOĞAN A., Akkaya M., Kansu E., Guc D.
CYTOTECHNOLOGY
, cilt.61, ss.45-53, 2009 (SCI-Expanded, Scopus)
2009
200995. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors
Bilensoy E., Sarisozen C., Esendagli G., Doğan A., Aktas Y., Şen M., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.371, ss.170-176, 2009 (SCI-Expanded, Scopus)
2009
200996. CONSTRUCTION OF BICISTRONIC B-GALACTOSIDASE REPORTER PLASMIDS FOR EUKARYOTIC EXPRESSION OF CD40 LIGAND (CD40L) GENE
Dolen Y., ESENDAĞLI G., Oskay S., Guc D.
IUBMB LIFE
, cilt.61, sa.3, ss.335, 2009 (SCI-Expanded, Scopus)
2009
200997. Fibronectin promotes the phorbol 12-myristate 13-acetate-induced macrophage differentiation in myeloid leukemia cells
ESENDAĞLI G., CANPINAR H., Yilmaz G., KAYMAZ F. F., Kansu E., Guc D.
INTERNATIONAL JOURNAL OF HEMATOLOGY
, cilt.89, sa.2, ss.167-172, 2009 (SCI-Expanded, Scopus)
2009
200998. Molecular and functional analysis of a novel recombinant clone of rat (Rattus norvegicus) CD40 ligand (CD40L) gene
ESENDAĞLI G., Gunel-Ozcan A., CANPINAR H., Guc D.
MOLECULAR BIOLOGY REPORTS
, cilt.36, sa.1, ss.83-89, 2009 (SCI-Expanded, Scopus)
2009
200999. Coexistence of different tissue tumourigenesis in an N-methyl-N-nitrosourea-induced mammary carcinoma model: a histopathological report in Sprague-Dawley rats
ESENDAĞLI G., Yilmaz G., CANPINAR H., Gunel-Ozcan A., Guc M. O., Guc D.
LABORATORY ANIMALS
, cilt.43, sa.1, ss.60-64, 2009 (SCI-Expanded, Scopus)
2009
2009100. Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene
ESENDAĞLI G., CANPINAR H., Yilmaz G., Gunel-Ozcan A., Guc M. O., Kansu E., et al.
CANCER BIOLOGY & THERAPY
, cilt.8, sa.2, ss.136-142, 2009 (SCI-Expanded, Scopus)
2008
2008101. Adhesion of beta1 integrin to fibronectin regulates CAM-DR phenotype via p21(WAF1/cip1) in HL60 acute myeloid leukemia (AML) cells
CANPINAR H., ESENDAĞLI G., Kansu E., Ozcan A. G., Guc D.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.38, sa.2, ss.97-104, 2008 (SCI-Expanded, Scopus, TRDizin)
2008
2008102. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer
Esendagli G., Bruderek K., Goldmann T., Busche A., Branscheid D., Vollmer E., et al.
LUNG CANCER
, cilt.59, sa.1, ss.32-40, 2008 (SCI-Expanded, Scopus)
2006
2006103. Salmonella typhimurium aroB encoding murine IL 18 or CD40L evaluation for gene therapy
AYDIN D., GÜNEL ÖZCAN A., MENAGER N., ESENDAĞLI G., GÜÇ M. O., HAYRAN K. M., et al.
Febs Journal
, cilt.273, ss.49-50, 2006 (SCI-Expanded, Scopus)
2003
2003104. pTARGET vector carrying IL 18 or CD40L genes for attenuated Salmonella typhimurium mediated gene therapy
BEK D., ESENDAĞLI G., GÜNEL ÖZCAN A., GÜÇ D., GÜÇ M. O., Kansu E.
Blood , cilt.102, ss.491, 2003 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2025
20251. Otoimmün Kökenli Merkezi Sinir Sistemi Hastaliklarinda B Hücrelerin İmmünfenotiplendirilmesi
KURAL MANGIT E., TAVUKÇUOĞLU DEMİR E., ACAR ÖZEN N. P., ESENDAĞLI G., TUNCER M. A.
12. NÖROİMMÜNOLOJİ OKULU, Kıbrıs (Kktc), 8 - 11 Mayıs 2025, (Özet Bildiri)
2024
20242. Memantine Loaded Magnetic Micro/Nanomotors for the Treatment of Alzheimer’s Disease
TEZEL TEMEL G., ÖZTÜRK E., Ulutürk S., ÖZTÜRK S. C., REÇBER T., TİMUR S. S., et al.
21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 09 Eylül 2024, (Özet Bildiri)
2023
20233. NUSİNERSEN TEDAVİSİ ALAN ERİŞKİN SPİNAL MUSKÜLER ATROFİ HASTALARINDA İNFLAMASYON VE GLİAL HÜCRE İLİŞKİLİ BİYOBELİRTEÇLERİN TESPİTİ
ARSLAN D., ERGÜL ÜLGER Z., gökşen s., ESENDAĞLI G., ERDEM ÖZDAMAR S., TAN M. E., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 Aralık 2023, (Özet Bildiri)
2023
20234. MİYASTENİK KRİZ İLE BAŞVURAN HASTALARDA YARDIMCI FOLİKÜLER T HÜCRE (TFH) VE YARDIMCI T HÜCRE 17 (TH17) İLİŞKİLİ SİTOKİNLERİN TEDAVİ ÖNCESİ VE SONRASI DEĞİŞKENLİĞİ
ARSLAN D., ERGÜL ÜLGER Z., gökşen s., ESENDAĞLI G., ERDEM ÖZDAMAR S., TAN M. E., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 Aralık 2023, (Özet Bildiri)
2023
20235. Evaluation of the Role of Glial Factors in the Pathogenesis of Spinal Muscular Atrophy
ARSLAN D., ERGÜL ÜLGER Z., gökşen s., İNAN B., ESENDAĞLI G., ERDEM ÖZDAMAR S., et al.
2023 Neuromuscular Study Group Meeting, Orlando, Amerika Birleşik Devletleri, 22 Eylül 2023, (Özet Bildiri)
2023
20236. Serum Cytokines Levels in Patients with Myasthenia Gravis and Their Changes After Treatment
ARSLAN D., ERGÜL ÜLGER Z., gökşen s., ESENDAĞLI G., ERDEM ÖZDAMAR S., TAN M. E., et al.
75th Annual Meeting of the American-Academy-of-Neurology (AAN), Boston, Amerika Birleşik Devletleri, 22 Nisan 2023, (Özet Bildiri)
2021
20217. Antiretroviral therapy causes a reduction in T-cell exhaustion, which is preserved after switching to a new therapy regimen
Özcan B., Tavukçuoğlu E., KARA E., Horzum U., AYAN G., SÖNMEZER M. Ç., et al.
18th European AIDS Conference (EACS 2021), London, Kanada, 27 Ekim 2021, cilt.1, ss.52-53, (Tam Metin Bildiri)
2019
20198. Büyük veriden hücre karakterizasyonuna: Transkripsiyon faktörü kataloglarınınoluşturulması
İMREN G., KARAOSMANOĞLU B., ÇELEBİ SALTIK B., ESENDAĞLI G., TAŞKIRAN Z. E.
Tıbbi Biyoloji ve Genetik Kongresi, Türkiye, 27 - 30 Ekim 2019
2019
20199. Effect of Formulation Parameters on PLGA and PLGA-PEG Nanoparticles Formulated with Double Emulsion Method
Arslan F. B., ÖZTÜRK K., ESENDAĞLI G., ÇALIŞ S.
8th BBBB International Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019
2019
201910. A Modified Cell Culture Method for Evaluation of Chitosan Nanoparticles
ÖZTÜRK K., Arslan F. B., Tavukçuoğlu E., ESENDAĞLI G., ÇALIŞ S.
8th BBBB International Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)
2019
201911. Folic Acid Conjugated Mesoporous Silica Nanoparticles For Enhanced Therapeutic Efficacy of Doxorubicin İn Breast Cancer
TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., TAVUKCUOĞLU E., AKTAŞ Y., et al.
8th BBBB Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, cilt.1, ss.184-186, (Tam Metin Bildiri)
2019
201912. STAT3-mediated atypical IFN-gamma signaling modulates the PD-1 ligands in CD11b-positive subpopulation of MDS and AML cells
Yoyen-Ermis D., Tunali G., Tavukcuoglu E., Ozkazanc D., Sutlu T., BÜYÜKAŞIK Y., et al.
17th International Congress of Immunology of the International-Union-of-Immunological-Societies (IUIS), Beijing, Çin, 19 - 23 Ekim 2019, cilt.49, ss.90, (Özet Bildiri)
2019
201913. A positive feedback mechanism between basal-like breast cancer cells and monocytes through STAT3/IL-1 beta/fibronectin can support chronic inflammation in the tumor microenvironment
Tunali G., ESENDAĞLI G.
17th International Congress of Immunology of the International-Union-of-Immunological-Societies (IUIS), Beijing, Çin, 19 - 23 Ekim 2019, cilt.49, ss.486, (Özet Bildiri)
2019
201914. Circulating myelin oligodendrocyte glycoprotein (MOG)-specific B cells stratify patients with serum MOG-antibodies
Winklmeier S., Schlueter M., Spadaro M., Thaler F. S., Vural A., Gerhards R., et al.
2nd Joint Meeting of the German-Society-for-Immunology (DGfl) and the Italian-Society-of-Immunology-Clinical-Immunology-and-Allergology (SIICA), Munich, Almanya, 10 - 13 Eylül 2019, cilt.49, ss.77, (Özet Bildiri)
2019
201915. Transcriptomic and immunophenotypic analyses on natural killer cells in RRMS patients under fingolimod therapy
Acar-Ozen N. P., TUNCER A., Ozkazanc D., Ozbay F. G., KARAOSMANOĞLU B., Goksen S., et al.
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.664-665, (Özet Bildiri)
2019
201916. Small cell lung cancer stem cells show adaptive resistance through effectively Inducing t cell activation and modulating the expression of co-inhibitory receptor
KURŞUNEL M. A., TAŞKIRAN Z. E., ESENDAĞLI G.
International Molecular Immunology Immunogenetics Congress IV (MIMIC IV), Bursa, Türkiye, 27 - 29 Nisan 2019, ss.29, (Özet Bildiri)
2018
201817. Analysis of spleen-derived MDSCs in pancreatic and gastric cancer patients
tavukcuoglu e., horzum u., Yoyen-Ermis D., aydın b., Yılmaz B. K., ÜNER A., et al.
1st European Symposium on Myeloid Regulatory Cells in Health and Disease, 1 - 03 Kasım 2018, (Tam Metin Bildiri)
2018
201818. Transcript variants of MDSC-related surface markers in breast cancer and colorectal cancer
horzum u., Yoyen-Ermis D., Yılmaz B. K., KARAKOÇ D., ESENDAĞLI G.
1st European Symposium on Myeloid Regulatory Cells in Health and Disease, 1 - 03 Kasım 2018, (Tam Metin Bildiri)
2018
201819. Splenectomy-Induced Leukocytosis Promotes Intratumoral Accumulation of Myeloid-Derived Suppressor Cells, Angiogenesis and Metastasis
Yoyen-Ermis D., Sevmis M., Aydin C., Bilgic E., KORKUSUZ P., ÜNER A., et al.
1st European Symposium on Myeloid Regulatory Cells in Health and Disease, 1 - 03 Kasım 2018, (Özet Bildiri)
2018
201820. APOPTOTIC GENE THERAPY BY NOVEL DEVELOPED PARTIALLY HYDROLYSED PEtOx BASED MICELLAR NANOCARRIERS ON MCF-7 BREAST CANCER CELLS
KARA A., ÖZTÜRK N., ESENDAĞLI G., ÖZKÖSE U. U., Gulyuz S., bolat z. b., et al.
IPTS2018, 17 - 19 Eylül 2018, (Özet Bildiri)
2018
201821. In Vitro Evaluation of Co-Loaded Drug Delivery, Theranostic Liposomes in Human Non-Small Cell Lung Cancer
KARPUZ M., KURŞUNEL M. A., SİLİNDİR GÜNAY M., DOĞAN A., ESENDAĞLI G., ÖZER A. Y.
19th International Pharmaceutical Technology Symposium, Antalya, Türkiye, 17 Eylül 2018, ss.182-183, (Tam Metin Bildiri)
2018
201822. PREPERATION, CHARACTERIZATION, CYTOTOXICITY EVALUATIONS OFFOLIC ACID CONJUGATED MESOPOROUS SILICA NANOPARTICLES
TONBUL H., ultav g., akbas s., sahin a., tavukcuoglu e., AKTAŞ Y., et al.
19th InternationalPharmaceutical Technology Symposium-IPTS 2018, 17 - 19 Eylül 2018, (Tam Metin Bildiri)
2018
201823. Characterization of Circulating Exosomes and Analysis of Exosomal microRNAs
zeynep t., AKKAYA ULUM Z. Y., YERSAL N., AKBABA T. H., Horzum U., ESENDAĞLI G., et al.
6th International Congress of the Molecular Biology of Association of Turkey, 5 - 08 Eylül 2018, (Özet Bildiri)
2018
201824. Preparation and Comparative Evaluation of Gemcitabine Loaded Polymeric Nanoparticles for Pancreatic Cancer Treatment
Arslan F. B., ÖZTÜRK K., ESENDAĞLI G., ÇALIŞ S.
45th Annual Meeting Exposition of the Controlled Release Society, 22 - 24 Temmuz 2018, (Özet Bildiri)
2018
201825. The Fibrogenic Activation Kinetics of Stromal Stem Cells in Three Different Skeletal Muscle Degeneration Models
ÖZDEMİR SAKA C., AKÇAY D., YÖYEN ERMİŞ D., ESENDAĞLI G., KOCAEFE Y. Ç.
43rd FEBS CONGRESS, 7 - 12 Temmuz 2018, (Tam Metin Bildiri)
2018
201826. Comparative Transcriptome Analysis of Distinct Stromal Cell Populations During Extracellular Matrix Remodeling in Skeletal Muscle
ÖZDEMİR SAKA C., AKÇAY D., YÖYEN ERMİŞ D., TAŞKIRAN Z. E., ESENDAĞLI G., KOCAEFE Y. Ç.
13th Meeting of the Mediterrranean Society of Myology, 27 - 29 Haziran 2018, cilt.37, ss.129-183, (Tam Metin Bildiri)
2019
201927. Leptinin Spermatogonyal Kok Hucreler Uzerindeki Etkisi
YERSAL N., KÖSE S., Utku H., ESENDAĞLI G., Sinan O., KORKUSUZ P.
XIV. Ulusal Histoloji ve Embriyoloji Kongresi, Türkiye, 10 Mayıs 2019 - 13 Mayıs 2018, (Özet Bildiri)
2018
201828. Gemcitabine delivery via dendrimer carriers decorated with anti-VGFR1 antibody to target tumor-induced myeloid cells
KURŞUNEL M. A., Yoyen Ermis D., OZTURK ATAR K., AYDIN Ç., OZKAZANC D., GURBUZ M. U., et al.
Myeloid Derived Suppressor Cells:Identification and implications in Human Diseases, 16 - 18 Nisan 2018, (Tam Metin Bildiri)
2017
201729. Passive Targeting of Gemcitabine Using Poly(Caprolactone) Nanoparticles for Cancer Treatment
ÖZTÜRK K., Arslan F. B., ESENDAĞLI G., ÇALIŞ S.
2nd Gazi Pharma Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri)
2017
201730. Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers
ÖZTÜRK K., ESENDAĞLI G., Gürbüz M. U., TÜLÜ M., ÇALIŞ S.
Advanced School in Nanomedicine, 25 - 28 Eylül 2017, (Özet Bildiri)
2017
201731. Dual effects of chlorophylline on breast cancer cell proliferation in vivo and in vitro
ÖZCAN M., Musad Y., ESENDAĞLI G., CANPINAR H., AKSOY Y.
42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, Jerusalem, İsrail, 10 - 14 Eylül 2017, cilt.284, ss.259, (Özet Bildiri)
2017
201732. Novel Folate-Conjugated Amphiphilic Cyclodextrin Nanoparticles For Paclitaxel Delivery in Recurrent Metastatic Breast Cancer
ERDOĞAR N., ESENDAĞLI G., NIELSEN T. T., ESENDAĞLI YILMAZ G., SARGON M. F., ÖNER L., et al.
Innovation in Medicine Summit-3, 11 - 13 Mayıs 2017, (Özet Bildiri)
2107
210733. NOVEL POLYMERIC MICELLES BASED ON Poly-(2-Ethyl-2-Oxazoline)-co-Poly(ethylenimine)-block-Poly(ɛ-caprolactone) PEtOx-co-PEI-b-PCL BLOCK COPOLYMER WITH VARIOUS HYDROLYSIS DEGREE TO EVALUATE THE EFFECT OF TRANSFECTION EFFICIENCY ON MCF-7 CELLS
KARA A., ÖZTÜRK N., ESENDAĞLI G., BOLAT z. b., GÜLYÜZ s., TELCİ D., et al.
AAPS 2017 NATIONAL BIOTECHNOLOGY CONGRESS, San Diego, Amerika Birleşik Devletleri, 01 Mayıs 2107 - 03 Mayıs 2017, (Özet Bildiri)
2017
201734. Increased monocytic myeloid-derived suppressor cells in small-cell lung cancer implicate interaction between small cell lung cancer cells and monocytes
KURŞUNEL M. A., Yoyen Ermis D., Horzum U., Esendagli D., ESENDAĞLI G.
Analysis and Clinical Monitoring ofMyeloid Regulatory Cells, Brno, Çek Cumhuriyeti, 1 - 03 Mart 2017, (Tam Metin Bildiri)
2016
201635. Comparing Intracellular Delivery of PLGA and Chitosan Nanoparticles Lessons and Challenges
ŞAHİN A., Yerlikaya F., AKTAŞ Y., ESENDAĞLI G., ÇAPAN Y.
GPEN 2016, 9 - 12 Kasım 2016
2016
201636. Intracellular delivery and intraperıtoneal retention of different sized PLGA nanoparticles prepared by nanoprecipitation method
ŞAHİN A., ESENDAĞLI G., Fırat Y., Serhat K., Yöyen Ermis D., Horzum U., et al.
18th International Pharmaceutical Technology Symposium-IPTS 2016, 18 - 21 Eylül 2016
2016
201637. The effect of fingolimod treatment on natural killer cells
Acar N. P., KARABUDAK R., Ozkazanc D., Sayat-Gurel G., ESENDAĞLI G., TUNCER A.
32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Kanada, 14 - 17 Eylül 2016, cilt.22, ss.176-177, (Özet Bildiri)
2016
201638. Effect of chlorophylline as an antioxidant molecule on glutathione and related enzymes in breast cancer model
ÖZCAN M., Beyramzadeh M., ESENDAĞLI G., AKSOY Y.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.408, (Özet Bildiri)
2016
201639. Active targeting of anti VEGFR 1 monoclonal antibody conjugated gemcitabine loaded dendrimers to pancreatic cancer and in vitro in vivo evaluation
ÖZTÜRK K., gurbuz u. m., TÜLÜ M., ESENDAĞLI G., ÇALIŞ S.
18th International Pharmaceutical Technology Symposium, 18 - 21 Eylül 2016, (Özet Bildiri)
2016
201640. Costimulatory signals derived from myeloid leukemia cells contribute to functional exhaustion in CD4(+) T cells
Ozkazanc D., BÜYÜKAŞIK Y., ESENDAĞLI G.
International Congress of Immunology (ICI), Melbourne, Avustralya, 21 - 26 Ağustos 2016, cilt.46, ss.1092-1093, (Özet Bildiri)
2016
201641. Targeting myeloid derived suppressor cells MDSCs in pancreatic cancer by gemcitabine loaded anti VEGFR1 antibody coated dendrimers carriers
ÖZTÜRK K., yöyen ermiş d., özkazanç d., gürbüz m. u., TÜLÜ M., ÇALIŞ S., et al.
3rd International Molecular Immunology & Immunogenetics Congress MIMIC-III, 27 - 30 Nisan 2016, (Özet Bildiri)
2017
201742. B7-H3 molekülünün küçük-hücreli akciğer kanseri için immünolojik biyobelirteç olarak değerlendirilmesi
KURŞUNEL M. A., ESENDAGLİ D., ESENDAĞLI G.
22. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017, (Tam Metin Bildiri)
2015
201543. THE PROTECTIVE ROLE OF CHLOROPHYLLINE Cu COMPLEX ON N METHYL N NITROSOUREA INDUCED BREAST CANCER MODEL
ÖZCAN M., BÜBER E., CEYHAN D., beyramzadeh m., BACANLI M., ESENDAĞLI G., et al.
XXVII. ULUSAL BİYOKİMYA KONGRESİ, 3 - 06 Kasım 2015, cilt.40, (Özet Bildiri)
2015
201544. Evaluation of Developed Dendrimer based Nanocarrier System for Pancreatic Cancer Therapy
ÖZTÜRK K., Gürbüz M., Tülü M., ESENDAĞLI G., ÇALIŞ S.
2015 AAPS Annual Meeting and Exposition, 25 Ekim - 29 Haziran 2015
2015
201545. Evaluation of Dendrimer Based Nanocarrier System for Pancreatic Cancer Therapy
ÖZTÜRK K., Gürbüz M. U., ESENDAĞLI G., TÜLÜ M., ÇALIŞ S.
2015 AAPS Annual Meeting, 25 - 29 Ekim 2015, (Tam Metin Bildiri)
2015
201546. Immune modulatory effects of the small peptide molecules derived from CXCL chemokines
Yöyen Ermiş D., Karaşar P., ESENDAĞLI G.
World Immuneregulation meeting – IX, 18 - 21 Mart 2015
2015
201547. In Vitro and In Vivo Evaluation of Tumor Targeted Nanoparticles for Paclitaxel Delivery with Folate conjugated Amphiphilic Cyclodextrin Derivatives
ERDOĞAR N., TERNDRUP N., ÖNER L., ESENDAĞLI G., BİLENSOY E.
4th European Conference on Cyclodextrins (EUROCD 2015), 6 - 09 Ekim 2015, (Özet Bildiri)
2015
201548. Mesenchymal stem cells induce proliferation of NCI-H82 small cell lung cancer
KOPRU C. Z., CAGNAN I., Akar-Soycan I., ESENDAĞLI G., KORKUSUZ P., ÖZCAN A.
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finlandiya, 17 - 20 Eylül 2015, cilt.26, (Özet Bildiri)
2015
201549. pCR3::GITRL transfected MSCs induce apoptotic cell death and SIVA1 expression in SCLC-21H lung cancer cell line
KOPRU C. Z., KORKUSUZ P., CAGNAN I., Akar-Soycan I., ESENDAĞLI G., ÖZCAN A.
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finlandiya, 17 - 20 Eylül 2015, cilt.26, (Özet Bildiri)
2015
201550. Granulocytic subset of myeloid derived suppressor cells in rats with mammary carcinoma
DÖLEN Y., GÜNAYDIN G., ESENDAĞLI G., GÜÇ D.
4TH EUROPEAN CONGRESS OF IMMUNOLOGY, 6 - 09 Eylül 2015, (Özet Bildiri)
2015
201551. Fibronectin production in basal like breast cancer cells is regulated by pro inflammatory cytokines and may influence myeloid cell maturation
TUNALI G., ESENDAĞLI G.
4th European Congress of Immunulogy, 6 - 09 Eylül 2015
2015
201552. Selective expression of CCRL2 transcript variants associates with inflammatory response in breast cancer
Sarmadi P., TUNALI G., YILMAZ G., Yılmaz K., ESENDAĞLI G.
4th European Congress of Immunulogy, 6 - 09 Eylül 2015
2015
201553. The effect of co stimulatory signals derived from acute myeloid leukemia cells AML on helper T lymphocyte activation and exhaustion
OZKAZANC D., ESENDAĞLI G.
4th European Congress of Immunology, 6 - 09 Eylül 2015
2015
201554. Nanopartiküller ile işaretli pGITRL aktarılmış mezenkimal kök hücrelerin küçük hücreli akciğer kanseri hücreleriyle görüntülenmesi
KÖPRÜ C. Z., GÜNEL ÖZCAN A., Cagnan I., AKAR SOYCAN İ., ESENDAĞLI G., KORKUSUZ P.
22.nci Elektron Mikroskopi Kongresi (EMK 2015), İstanbul, Türkiye, 2 - 04 Eylül 2015
2015
201555. Can acute myeloid leukemia cells act as myeloid derived suppressor cells for immune escape
YÖYEN ERMİŞ D., TUNALI G., KARAŞAR P., ESENDAĞLI G.
Young Investigator Workshop Immunosystem and Microenvironments Implications for Cancer Therapy, 24 - 26 Ağustos 2015, (Özet Bildiri)
2015
201556. The protective role of chlorophylline-Cu complex on N-methyl-N-nitrosourea induced breast cancer model in Spraque Dawley Rats: glutathione and DNA damage levels
ÖZCAN M., BÜBER E., Ceyhan D., BACANLI M., Beyramzadeh M., ESENDAĞLI G., et al.
40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Almanya, 4 - 09 Temmuz 2015, cilt.282, ss.265, (Özet Bildiri)
2015
201557. Optimization by 32 Factorial Design of Tumor Targeted Nanoparticles for Paclitaxel Delivery with Folate conjugated Amphiphilic Cyclodextrin
ERDOĞAR N., ÖNER L., ESENDAĞLI G., NİELSEN T., BİLENSOY E.
EUFEPS Annual Meeting, 15 - 17 Haziran 2015
2015
201558. Evaluation of Th17 cell infiltration in thymectomy materials of acetycholine receptor antibody positive myasthenia gravis patients
Bekircan Kurt E., Mehdikanova L., Öner S., ESENDAĞLI G., KARABULUT E., Kurne A.
AAN 67th Annual Meeting, 6 - 10 Nisan 2015
2013
201359. Formyl-methionyl-leucyl-phenylalanine (fMLP) peptide as an adjuvant in experimental autoimmune encephalomyelitis (EAE): modulation of neutrophil granulocytes
KILIÇ A., Tuncer-Kurne A., ESENDAĞLI G., Sayat G., TALİM B., KARABUDAK R.
29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Danimarka, 2 - 05 Ekim 2013, cilt.19, ss.136, (Özet Bildiri)
2013
201360. NMU ARACILI MEME KANSERİ MODELİNDE MYELOİD KÖKENLİ BASKILAYICI HÜCRELERİN TANIMLANMASI
DÖLEN Y., GÜNAYDIN G., ESENDAĞLI G., GÜÇ D.
22. ULUSAL İMMÜNOLOJİ KONGRESİ, Türkiye, 27 - 30 Nisan 2013, (Özet Bildiri)
2012
201261. Evaluation of Th17-related parameters in multiple sclerosis patients under immunomodulatory IFN-beta 1 therapy
Sayat G., Kurne A., ESENDAĞLI G., Guc D., KARABUDAK R.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.77-78, (Özet Bildiri)
2012
201262. Functional analysis of neutrophils cultured in supernatant of CXCL7 overexpressing lung cancer cells
ÜNVER N., ESENDAĞLI G., Guc D.
European Congress of Immunology, Glasgow, Birleşik Krallık, 5 - 08 Eylül 2012, cilt.137, ss.608, (Özet Bildiri)
2012
201263. Dynamic induction of immune escape by activated T cells via regulation of B7-ligands on myeloid leukemia cells
ESENDAĞLI G., Dolen Y.
European Congress of Immunology, Glasgow, Birleşik Krallık, 5 - 08 Eylül 2012, cilt.137, ss.206-207, (Özet Bildiri)
2012
201264. Differences of myeloid cell subsets in a chemically induced rat breast carcinoma model
DOLEN Y., GÜNAYDIN G., ESENDAĞLI G., Guc D.
European Congress of Immunology, Glasgow, Birleşik Krallık, 5 - 08 Eylül 2012, cilt.137, ss.606, (Özet Bildiri)
2012
201265. Cloning of atypical chemokine receptors CRAM-A and CRAM-B for comparative functional analysis
Sarmadi P., ESENDAĞLI G.
European Congress of Immunology, Glasgow, Birleşik Krallık, 5 - 08 Eylül 2012, cilt.137, ss.188, (Özet Bildiri)
2006
200666. Salmonella typhimurium aroB-encoding murine IL-18 or CD40L: evaluation for gene therapy
Aydin D., Gunel-Ozcan A., Menager N., Esendagli G., Guc M. O., Hayran M., et al.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.49-50, (Özet Bildiri)
2003
200367. pTARGET vector carrying IL-18 or CD40L genes for attenuated Salmonella typhimurium mediated gene therapy.
Bek D., Esendagli G., Gunel-Ozcan A., Guc D., Guc M., Kansu E.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 Aralık 2003, cilt.102, (Özet Bildiri)
Kitaplar
2018
20181. Biomaterials Surface Properties: Impllications in Immune Response
ENDOĞAN TANIR T., ESENDAĞLI G., AKSOY E. A.
Biomaterials and Immune Response: Complications, Mechanisms and Immunomodulation, Vrana, Nihal Engin, Editör, CRC Press Taylor Francis Group, ss.121-140, 2018
Desteklenen Projeler
2014 - Devam Ediyor
2014 - Devam Ediyor
Prostat ve meme kanseri teşhis ve tedavisinde kullanılacak Poli 2 Etil 2 Oksazolin Petox esaslı çok işlevsel taşıyıcı sistemlerin geliştirilmesi
TÜBİTAK Projesi
ESENDAĞLI G. (Yürütücü)
2023 - 2026
2023 - 2026Kolon kanserinin tedavi etkinliğini artırmak amacıyla; enterik kapsüllere doldurulmuş kuersetin yüklü silika nanopartikülleri içeren nanofiber formülasyonlarının geliştirilmesi, karakterizasyonları, in vitro ve in vivo çalışmaları
TÜSEB B Grubu AR-GE Projesi
Akdağ Çaylı Y., Gülsün İnal T., Esendağlı G., Öztürk S. C., İnal M.(Yürütücü)
2023 - 2025
2023 - 2025Covid 19’a Karşı Multiepitop (Wuhan, Delta, Omicron B.A/5 ) Sentetik Peptit Aşısı Araştırma Geliştirme Çalışması
Türkiye Sağlık Enstitüleri Başkanlığı (TÜSEB) Araştırma Projesi
Aydın S. (Yürütücü), Ünal S., Tatar Yılmaz G., Özçubukçu S., Özkul A., Esendağlı G., et al.
2020 - 2024
2020 - 2024
Kolorektal kanserde nötrofil altpopülasyonlarının moleküler - fonksiyonel analizi ve biyobelirteç olarak değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
ESENDAĞLI G. (Yürütücü), TAŞKIRAN Z. E., Tavukçuoğlu E., SUCULARLI C., KARAKOÇ D.
2021 - 2022
2021 - 2022Folat reseptörü ifade eden immün hücrelerin tümör mikroçevresine infiltrasyonu ve immünoterapi amacıyla modülasyonu
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
ESENDAĞLI G. (Yürütücü), ÖZTÜRK S. C., Gökşen S.
2020 - 2021
2020 - 2021
Mikrotübül İnhibitörlerinin Kanser Hücrelerinde Tehlike-ilişkili Moleküler Desen Düzeylerine Etkisinin Araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Y.Lisans
ESENDAĞLI G. (Yürütücü), Ulusoy S.
2019 - 2021
2019 - 2021Klorokojik Asit Türevi Mannich Bazı Bileşiğinin UV ile İndüklenmiş Melanoma Karşı Koruyucu Etkisinin Değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ERCAN A. (Yürütücü), ÖZTÜRK S. C., AYTEMİR M., ESENDAĞLI G.
2018 - 2021
2018 - 2021Farklı aktivasyon basamaklarına ilerletilen yardımcı T hücrelerinde adezyon ve migrasyon mekanizmalarının incelenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
ESENDAĞLI G. (Yürütücü), TAŞKIRAN Z. E., Horzum U.
2017 - 2020
2017 - 2020Paklitaksel yüklü siklodekstrin nanopartiküllerin antitümöral etkinliğinin araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
BİLENSOY E. (Yürütücü), Varan G., ESENDAĞLI G., Varan C.
2018 - 2019
2018 - 2019
T lenfosit yanıtlarının nötrofil, monosit ve akciğer kanseri hücrelerini içeren kokültürlerde analizi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ESENDAĞLI G. (Yürütücü), ÖZBAY F.
2018 - 2019
2018 - 2019
Meme kanseri hücreleri tarafından üretilen fibronektinin miyeloid hücre karakteri üzerine etkisi
Yükseköğretim Kurumları Destekli Proje , BAP Doktora
ESENDAĞLI G. (Yürütücü), TUNALI G.
2017 - 2019
2017 - 2019Hacettepe Üniversitesi Tıp Fakültesi Dergisi Acta Medica'nın Yapılandırılması
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
KARAKOÇ D. (Yürütücü), YORGUN H., ÜNAL CANGÜL Ş., ER ÖZTAŞ Y., ESENDAĞLI G., KONAŞ E., et al.
2017 - 2019
2017 - 2019
Küçük Hücreli Dışı Akciğer Kanserine Aktif Hedeflendirilmiş Nanoboyutlu Teranostik Kombine İlaç Taşıyan Sistemlerin Formülasyonu ve Etkinliğinin Saptanması
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
ÖZER A. Y. (Yürütücü), SİLİNDİR GÜNAY M., ESENDAĞLI G., KARPUZ M.
2015 - 2019
2015 - 2019Multiple Skleroz Hastalarında CCRL2 Atipik Kemokin Reseptör Polimorfizminin Kemokin Düzeyleri ve Hastalık Süreci ile İlişkisi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
TUNCER M. A. (Yürütücü), ACAR N. P., ESENDAĞLI G., SAYAT-GÜREL G., KARABUDAK R.
2017 - 2018
2017 - 2018Leptinin spermatogonyal kök hücre kriyoprezervasyonundaki etkisinin araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
KORKUSUZ P. (Yürütücü), ÖZKAVUKCU İ. S., YERSAL N., ESENDAĞLI G., KÖSE S.
2017 - 2018
2017 - 2018
Meme kanserinin karaciğer metastazında karaciğer rezeksiyonunun immünolojik etkileri
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
KARAKOÇ D. (Yürütücü), DİNÇER H. A., Ermiş D. Y., ESENDAĞLI G., Horzum U.
2017 - 2018
2017 - 20184T1 Hücreleriyle Farelerde Oluşturulan Meme Karsinomu Üzerine Usnik Asit Sekonder Metabolitinin in vivo Etkileri
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
KARABULUT İ. (Yürütücü), DİNÇSOY A. B., TUNCER M., CANSARAN DUMAN D., ESENDAĞLI G., YÖYEN ERMİŞ D., et al.
2017 - 2018
2017 - 2018PDL2 kostimülatör molekülünü ifade eden akut miyeloid lösemi hücrelerinin yardımcı T hücre aktivasyonuna etkisi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
ESENDAĞLI G. (Yürütücü), Tavukçuoğlu E.
2017 - 2018
2017 - 2018
Meme Kanseri Tedavisinde Aktif Hedeflendirme Amacıyla Kullanılmak Üzere Nano Boyutlu İlaç Taşıyıcı Sistemlerin Nanofarmasötikler Tasarımı ve in vitro Değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
GÜRSOY R. N. (Yürütücü), TİMUR S. S., ESENDAĞLI G.
2017 - 2017
2017 - 2017
MD ANDERSON Kanser Enstitüsü tarafından düzenlenen Global Academic Program 2017 Kongresine Katılım
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ESENDAĞLI G. (Yürütücü), KURŞUNEL M. A.
2016 - 2017
2016 - 2017B lenfoma hücrelerinde B7 ailesi kostimülatör moleküllerin araştırılması ve T hücre aktivasyonuna ve yorulmasına etkileri
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ESENDAĞLI G. (Yürütücü), ÜNER A., KURŞUNEL M. A.
2016 - 2017
2016 - 2017CXCL KEMOKİNLERDEN TÜREVLENEN İMMÜNMODÜLATÖR PEPTİTLER
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ESENDAĞLI G. (Yürütücü)
2016 - 2016
2016 - 2016Miyeloid lösemi hücrelerinden kaynaklanan kostimülatör sinyaller CD4 T hücrelerde fonksiyonel tükenmeye neden olur
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ESENDAĞLI G. (Yürütücü)
2015 - 2016
2015 - 2016
Yardımcı T hücre yanıtları bazalbenzeri meme kanseri hücreleri tarafından devam ettirilir ve PD1 ligandlarının artışı ile immün düzenlenmesini sağlar
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ESENDAĞLI G. (Yürütücü), Karaşar P.
2015 - 2016
2015 - 2016Uyarılabilen kostimülatör ligand (ICOS-LG) eksprese eden akut miyeloid lösemi (AML) hücrelerinin T lenfosit aktivasyonuna ve yorulmasına etkisi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ESENDAĞLI G. (Yürütücü), Özkazanç D.
2014 - 2016
2014 - 2016İmmünoterapi Amaçlı Deneysel Onkoloji Sistemlerinin Geliştirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Alt Yapı
ESENDAĞLI G. (Yürütücü)
2013 - 2016
2013 - 2016CXCL kemokin öncül dizilerinden türevlenen küçük peptit moleküllerinin immün düzenleyici etkisinin değerlendirilmesi
TÜBİTAK Projesi
ESENDAĞLI G. (Yürütücü)
2014 - 2015
2014 - 2015All-trans retinoik asit (ATRA) ve 1?,25-dihidroksivitamin D3 (vitamin D3) ile uyarılan akut miyeloid lösemi hücrelerinin T hücre yanıtları üzerine etkisi.
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ESENDAĞLI G. (Yürütücü)